These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30295842)

  • 1. Separation and Identification of Isomeric and Structurally Related Synthetic Cannabinoids Using 2D Liquid Chromatography and High Resolution Mass Spectrometry.
    Eckberg MN; Arroyo-Mora LE; Stoll DR; DeCaprio AP
    J Anal Toxicol; 2019 Apr; 43(3):170-178. PubMed ID: 30295842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isomeric analysis of synthetic cannabinoids detected as designer drugs].
    Uchiyama N; Kikura-Hanajiri R; Shoda T; Fukuhara K; Goda Y
    Yakugaku Zasshi; 2011; 131(7):1141-7. PubMed ID: 21720146
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Martek BA; Mihelač M; Gazvoda M; Virant M; Urankar D; Krivec M; Gostič T; Nemec B; Koštrun B; Janežič M; Klemenc S; Košmrlj J
    Drug Test Anal; 2019 Apr; 11(4):617-625. PubMed ID: 30730110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
    Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
    J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable Data Independent Acquisition and Data Mining Exploring Feature-Based Molecular Networking Analysis for Untargeted Screening of Synthetic Cannabinoids in Oral Fluid.
    de Albuquerque Cavalcanti G; Moreira Borges R; Reis Alves Carneiro G; Costa Padilha M; Gualberto Pereira HM
    J Am Soc Mass Spectrom; 2021 Sep; 32(9):2417-2424. PubMed ID: 34399051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of two-dimensional liquid chromatography coupled with mass spectrometry for the separation of active compounds in Gegen Qinlian decoction].
    Guo F; Wang Y; Wang R; Yan C
    Se Pu; 2008 Jan; 26(1):15-21. PubMed ID: 18438018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices.
    Castaneto MS; Wohlfarth A; Desrosiers NA; Hartman RL; Gorelick DA; Huestis MA
    Drug Metab Rev; 2015 May; 47(2):124-74. PubMed ID: 25853390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of ultra high performance liquid chromatography with time of flight detection for the identification of synthetic cannabinoids in seized drugs.
    Marginean I; Rowe WF; Lurie IS
    Forensic Sci Int; 2015 Apr; 249():83-91. PubMed ID: 25679986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS.
    Rodrigues WC; Catbagan P; Rana S; Wang G; Moore C
    J Anal Toxicol; 2013 Oct; 37(8):526-33. PubMed ID: 23946452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of synthetic cannabinoids in herbal blends by means of nano-liquid chromatography.
    Merola G; Aturki Z; D'Orazio G; Gottardo R; Macchia T; Tagliaro F; Fanali S
    J Pharm Biomed Anal; 2012 Dec; 71():45-53. PubMed ID: 22944357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS.
    da Cunha KF; Oliveira KD; Huestis MA; Costa JL
    J Anal Toxicol; 2020 Oct; 44(7):697-707. PubMed ID: 32685960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
    Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
    Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution two-dimensional liquid chromatography coupled with mass spectrometry for robust and sensitive characterization of therapeutic antibodies at the peptide level.
    Stoll DR; Lhotka HR; Harmes DC; Madigan B; Hsiao JJ; Staples GO
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Dec; 1134-1135():121832. PubMed ID: 31790917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of a two-dimensional liquid chromatography-supercritical fluid chromatography-mass spectrometry (2D-LC-SFS-MS) system to assess "in-vivo" inter-conversion of chiral drug molecules.
    Goel M; Larson E; Venkatramani CJ; Al-Sayah MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():89-95. PubMed ID: 29579733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method development, validation, and application for simultaneous determination of 56 new psychoactive substances in surface water by LC-MS/MS.
    Atasoy Aydin A; Gören İE; Yavuz Guzel E; Daglioglu N
    Environ Sci Pollut Res Int; 2023 Aug; 30(36):85920-85929. PubMed ID: 37394566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
    Musah RA; Domin MA; Walling MA; Shepard JR
    Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A liquid chromatography-mass spectrometry method based on class characteristic fragmentation pathways to detect the class of indole-derivative synthetic cannabinoids in biological samples.
    Mazzarino M; de la Torre X; Botrè F
    Anal Chim Acta; 2014 Jul; 837():70-82. PubMed ID: 25000860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.